Doxycycline Injection [Doxy] ( DrugBank: Doxycycline )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 34 | 神経線維腫症 | 1 |
34. 神経線維腫症
臨床試験数 : 133 / 薬物数 : 186 - (DrugBank : 67) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 190
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05521048 (ClinicalTrials.gov) | September 19, 2022 | 26/8/2022 | Doxycycline in Cutaneous Schwannoma (NF2) | Doxycycline Injection of Cutaneous Schwannoma in Neurofibromatosis Type 2 | Neurofibromatosis Type 2 | Drug: Doxycycline Injection [Doxy] | Massachusetts Eye and Ear Infirmary | NULL | Recruiting | 8 Years | N/A | All | 19 | Phase 1/Phase 2 | United States |